FDA's Off-Label Comms Guidance Is A Reluctant Step Forward
By Jeffrey Shapiro and Lisa Dwyer · November 6, 2023, 2:37 PM EST
Last month, the U.S. Food and Drug Administration published a draft guidance making recommendations for permissible proactive communications to health care providers regarding unapproved uses of approved or cleared medical products,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login